WE ARE THE LEADER IN HEALTHY AGING knows that an increasing number of people are adopting holistic wellness lifestyles and seeking alternative solutions that go beyond what conventional pharmaceutical medicines can offer
The APAC region is leading the global GLP-1 receptor agonist market, characterized by rapid growth driven by countries such as China, Japan, and India
International immunopharmacology, 2013, 15(2): 240- 245
Lets be really honest with you
Of course, its unlikely one would know that they were allergic to these medications prior to taking them, but if an allergic reaction occurs, medical attention should be sought urgently
Paul Sarmiento , Senior Medical Director, Clinical Quality Since the first oral GLP-1 for weight loss was approved in late December 2025, commercials may have led people to believe all the barriers have been removed